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Abstract
Here we present the Transcription Factor Encyclopedia (TFe), a new web-based compendium of mini review
articles on transcription factors (TFs) that is founded on the principles of open access and collaboration. Our
consortium of over 100 researchers has collectively contributed over 130 mini review articles on pertinent human,
mouse and rat TFs. Notable features of the TFe website include a high-quality PDF generator and web API for
programmatic data retrieval. TFe aims to rapidly educate scientists about the TFs they encounter through the
delivery of succinct summaries written and vetted by experts in the field. TFe is available at http://www.cisreg.ca/
tfe.
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Background
As modulators of gene expression, transcription factors
(TFs) act on all eukaryotic biochemical systems, driving
‘networks’ or ‘regulatory programs’ that define the devel-
opmental stages of life and maintain cells in dynamically
changing microenvironments. From regulating muscle
differentiation in embryonic development (MYOD) [1]
to helping the kidneys reclaim water at times of dehy-
dration (NR3C2) [2] and even instigate oncogenesis
(MYC) [3], the pervasive roles of TFs are becoming
increasingly appreciated and experimentally character-
ized. TFs are amongst the most highly studied class of
proteins. Even though TFs comprise fewer than 5% of
human protein-encoding genes [4,5], over 16% of gene-
related papers address members of this critical class
(Figure 1).
Increasingly, TFs are the focus of research aimed at
deciphering the complex regulatory programs that allow
a single genome to specify hundreds of phenotypically
distinct cell types. The study of stem cell differentiation
is dominated by efforts to understand how the activation
of individual TFs can direct the progression to specific
lineages. Perhaps the most important of these advances
in recent years is the realization that, by introducing
specific ‘sets’ of TFs into terminally differentiated cells,
one can induce these cells to return to a pluripotent
capacity [6,7]. A complete understanding of TFs and the
processes that alter their activity is a fundamental goal
of modern life science research.
Rapidly advancing knowledge in TFs is nearly impossible
to track, with over 8,000 TF-related papers published in
2009 alone (Figure 1). In this light, the authors of this
work believe that non-TF researchers are sometimes con-
fronted with the need to understand the properties of cer-
tain TFs that they come across within their research, as a
potential participant in some differentiation, signaling or
regulatory pathway they are studying. In this scenario, an
accessible, high quality synopsis of the TF can catalyze
rapid progress in the study, allowing researchers to chart
an efficient approach. Such synopses have traditionally
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Figure 1 New journal articles associated with human or mouse TFs. Over the past five years, 216,421 journal articles associated with human
or mouse genes have been published and indexed in NCBI PubMed. This amount represents 5.59% of all articles published and indexed during
the same time frame (3,871,190 articles). Out of the 216,421 articles associated with human or mouse genes, at least 34,943 are associated with
human or mouse TFs, or 16.15%. This is astounding when considering that known TFs represent only 5% of the genome. The proportion of
journal articles associated with TFs has also been rising steadily over the past five years - from 15.47% in 2005 to 16.81% in 2009. These figures
were determined with a conservative set of approximately 3,200 human and mouse TF genes derived from the works of Fulton et al. [4] and
Vaquerizas et al. [5] and the publicly available ‘gene2pubmed’ annotation from NCBI.
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been obtained from published review articles, but the need
for timely information about the growing pool of actively
studied genes has increasingly led researchers to online
information sources.
In the Internet Age, gene-specific resources have
emerged that present information gathered from highly
specialized biomedical databases. Examples of such
resources include Entrez Gene [8] and GeneCards [9].
While automated content can be useful, many research-
ers seek summary descriptions of the proteins. The clas-
sic UniProt/Swiss-Prot [10,11] model for curated content
is often viewed as a gold standard, while automated sys-
tems have emerged to extract key sentences from the
research literature, such as iHOP [12] and WikiGenes
[13]. The community participation model for maintaining
current information exemplified by Wikipedia has argu-
ably not been proven successful for small communities
with specialized interests and need for peer-reviewed
content, perhaps reflecting the limited time available
from the small cadre of qualified experts. The Gene Wiki
project within Wikipedia has been the most advanced
effort, providing automated stub articles for many genes
within the confines of Wikipedia [14]. However, the
absence of a rigorous and enforced peer review process
and the lack of oversight in monitoring contributor quali-
fications makes the model less than ideal for scientists
who seek bona fide information in the digital realm.
TFs are proteins with special abilities and attributes not
found in other classes of proteins. For example, they often
work in pairs or networks to modulate specific regulatory
pathways. They directly or indirectly bind to DNA. Some
also interact with ligands or hormones. In short, the
unique properties of TFs place special demands on - and
presents opportunities for innovation with regards to - the
kind of information TF-specific biomedical resources can
offer, and how this information can be displayed to users
such that it is intuitive, sensible, and helpful. There are
many different kinds of TF-specific useful data that can be
captured. Sequence-specific DNA binding TFs act on tar-
get genes, interact with other TFs to achieve specificity in
action, and have structural characteristics that are predic-
tive of DNA interaction mechanisms. A well-characterized
TF will be represented by a binding profile that defines the
target sequences to which it can bind. These class-specific
properties have spurred the development of key databases,
such as JASPAR [15], PAZAR [16] and TRANSFAC® [17].
These efforts, however, are constrained by limited capacity
to identify and curate data from the scientific literature.
Based on the importance of TFs, the rapid accumulation
of research advances in the scientific literature, and the
need to provide class-specific information, we have created
a new web-based platform called the Transcription Factor
Encyclopedia (TFe). TFe’s mission is to facilitate the cura-
tion, evaluation, and dissemination of TF data. TFe
espouses the principles of open access and promotes colla-
boration within the TF research community. It rewards
scientists for contributing their data, and aims to optimize
content quality ensuring expert editorship and multiple
levels of peer review, both internal and external. TFe is
curated and managed by the TFe consortium, a collabora-
tion of over 100 TF researchers from throughout the
world (see Figure 2 for the list of completed mini review
articles that they contributed, and Figure 3 for their distri-
bution by country). The objective of the TFe consortium
is to produce concise mini review articles on pertinent
human and mouse TFs, and to accelerate the curation of
TF-specific data.
To date, the TFe consortium has prepared over 800 TF
mini review articles, 136 of which are sufficiently com-
plete to be presented here in the inaugural paper. Overall,
the TFe database contains 184 original tables and dia-
grams, 221 TF binding site profiles, 3,083 non-redundant
binding sequences, 2,334 genomic targets, 212 three-
dimensional structural predictions, 6,308 protein-protein
and protein-ligand interactions, 42,500 TF-to-disease
predictions based on Medical Subject Headings (MeSH),
and more.
The long-term goal of TFe is to create an online ency-
clopedic collection about well-studied TFs, combining a
mixture of both expert-curated and automatically popu-
lated content.
Resource content
In this paper we present a collection of 136 mini review
articles about human and mouse TFs. These articles are
available on the TFe website [18]. Two versions of every
article are available. A definitive version can be viewed
online, while an abridged version can be downloaded in
Portable Document Format (PDF) from the website. A
sample PDF article is enclosed in Additional file 1, while
Additional file 2 contains the raw data files.
The completed articles represent 15% of all TF articles
that have been pre-populated with automated content in
TFe. As for the remaining articles, most are awaiting an
expert volunteer author or remain at a preliminary state of
development. An ongoing effort aims to recruit appropri-
ate authors to curate these ‘orphaned’ articles. In total,
TFe currently hosts 803 TF articles, 216 of which are
human, 585 of which are mouse, and 2 of which are rat.
While TFs that bind directly to DNA are considered for
inclusion in TFe at this time, a few contributed articles
have addressed other TFs. Recent research has suggested
that there are well over 1,300 TFs in the human genome
[4,5]. With the increasing availability of data, our goal is to
eventually characterize all TFs in the human and mouse
genomes. See Additional file 3 for an inventory of all TF
articles currently available in TFe alongside their classifica-
tion, which is discussed in further detail below.
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Article structure
To ensure uniformity, all TF articles in TFe are written
in a standardized format that was established in
response to input and feedback from consortium
members. The style emphasizes relatively short articles -
accompanied by a few figures and up to 75 references.
These articles are concise, informative, and cater to a
broad audience of life science researchers.
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Figure 2 Released mini review articles. These mini review articles - listed in alphabetical order - are those that have been sufficiently
completed and released by their respective authors. These articles can be accessed at [43].
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The article page (shown in Figure 4b) is the corner-
stone of the TFe website, as it is where articles are
accessed. Articles in TFe are organized into ten tabbed
sections titled ‘Summary’, ‘Structure’, ‘TFBS’ (TF binding
site), ‘Targets’, ‘Protein’, ‘Interactions’, ‘Genetics’,
‘Expression’, ‘Ontologies’, and ‘Papers’ (that is, refer-
ences) (Figure 5). Above the tabs lies a standard header
that displays pertinent information regarding the TF,
including the TF symbol, species, classification, the date
of the most recent revision, and an article completion
score bar (Figure 5). Sections generally contain a mix-
ture of author-curated and automatically populated con-
tent, typically in the form of an expert-written overview
text - the author-curated portion - followed by several
additional headings filled with a mixture of author-
curated and automatically populated content. See Figure
6 for a comprehensive list of all automatically populated
and manually curated content available in the article
page. The automatically populated content represents
data that we have incorporated into TFe from second
and third party resources, including: BioGRID [19],
Ensembl [20], Entrez Gene [8], Gene Ontology [21],
MeSH [22], the Mouse Genome Database [23], Online
Mendelian Inheritance in Man (OMIM) [24], PAZAR
[25], RCSB Protein Data Bank [26], the UCSC Genome
Browser [27] and the Allen Brain Atlas [28]. More
details on the software tools and data repositories uti-
lized in the generation of automatically populated con-
tent found in each tab are presented in Table 1.
Each section - with the exceptions of the ‘Ontologies’
and ‘Papers’ sections - begins with a brief, expert-written
summary statement from the authors followed by rele-
vant figures, lists, and tables. For instance, the ‘Sum-
mary’ section is designed to begin with a 500-word
(maximum) overview followed by one or two captioned
figures. The ‘Targets’ section contains a 200-word over-
view focusing on the TF’s regulatory role, followed by a
table of genomic targets populated by the author and
additional data automatically extracted from PAZAR.
The expert-written summaries in TFe are meant to pro-
vide the reader with some perspective, highlight key
points, and reveal tacit knowledge. For a complete list of
features available in each section, please see Additional
file 4.
Here we discuss each of the ten tabbed sections -
‘Summary’, ‘Structure’, ‘TFBS’, ‘Targets’, ‘Protein’, ‘Inter-
actions’, ‘Genetics’, ‘Expression’, ‘Ontologies’, and
‘Papers’ - in greater detail.
Summary tab
The ‘Summary’ tab presents insightful overview text
written by expert authors, one or more figures as sup-
plied by them, and a list of relevant references. Authors
also have the option to post noteworthy links - for
instance, to a Wikipedia entry for the TF.
Like every other tab, the ‘Summary’ tab user interface
is a content viewer and editor combined into one.
When expert authors wish to implement changes to
their articles, they may ‘sign in’ to TFe using their per-
sonalized user accounts. After this is done, they are able
to see the normally hidden editing interface that allows
them to upload text, figures, figure captions, references,
external links, and data, depending on the tab. The
Figure 3 Worldwide distribution of authors by country. The TFe consortium comprises 114 authors from 13 countries. The exact distribution
is as follows: Australia, 2; Canada, 25; Denmark, 2; France, 6; Germany, 2; Italy, 2; Poland, 2; Spain, 4; Sweden, 2; Switzerland, 4; the Netherlands, 4;
the United Kingdom, 14; and the United States, 45.
Yusuf et al. Genome Biology 2012, 13:R24
http://genomebiology.com/2012/13/3/R24
Page 5 of 25
editing interface supports the widely used wiki syntax to
allow basic text formatting, such as bolding, italicizing,
underlining, and the creation of bulleted and numbered
lists. All text entered in wiki syntax is converted to
HTML by a local installation of the MediaWiki software.
Authors also have the option to add PubMed references
Figure 4 TFe user interface. Shown in this figure are three screenshots from the TFe web-based user interface. Built around HTML, JavaScript
and CSS standards, the TFe user interface is a quick and powerful method of viewing, downloading, and editing TFe data. Pages visualized in
this figure are: (a) the home page; (b) the article page; and (c) the classification page.
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anywhere in their text by using special tags that look
like ‘(pmid:16371163)’ - without the quotes. These tags
are automatically converted to a proper citation (Van-
couver style) by the TFe software. Figures can be
uploaded in many different image formats, while figure
captions are submitted as text. PubMed citations are
also supported in figure caption text.
Structure tab
The ‘Structure’ tab contains author-provided overview text
regarding the structural properties of the TF, followed by -
if available - the predicted three-dimensional structure of
the TF’s DNA binding domain. These ‘structural predic-
tions’, which were created by the consortium using a cus-
tom-made pipeline, are available for download as both
high-resolution Portable Network Graphics (PNG) images
and Protein Data Bank (PDB) formatted files. The materi-
als and methods used in their construction are discussed
in the Materials and methods section of this paper.
TFBS tab
A key property of TFs is the DNA sequences to which
they bind. In the world of TF research, such DNA
sequences are often called ‘transcription factor binding
sites’, or ‘TFBS’ for short. Knowledge of TFBS patterns
is key to identifying putative binding sites in genomic
sequences and to the identification of sets of genes regu-
lated by the TF in promoter analysis.
In light of this, disseminating TFBS data is a crucial
part of TFe’s mission. The ‘TFBS’ tab contains a sum-
mary of the DNA binding characteristics of the TF,
alongside one or more DNA binding target site data,
when sufficient data are available. A graphical depiction
of the target site pattern is displayed in the form of a
sequence logo, along with a brief summary text from the
author. This information is extracted from the PAZAR
regulatory sequence database.
TFe authors are able to create new binding models by
inputting a list of binding sites, experimental evidence,
and references in the ‘TFBS’ tab through a submission
interface that is visible to authors only. It is possible for
authors to submit target sequences that exist in a gen-
ome, or artificial sites, such as those generated in a
SELEX (Systematic Evolution of Ligands by Exponential
Enrichment) experiment. When we receive a submission
through this TFBS form system, we forward the supplied
Figure 5 Tour of the user interface. (A) The project logo links back to the homepage. (B) The ‘quick search’ and ‘sign in’ widgets are
conveniently placed near the top of the page. (C) The vertical site navigation bar offers fast access to all available pages in the site. (D) The
official symbol, name, and authors are prominently placed to immediately grab the user’s attention. Beneath the authors’ names is the date of
the most recent revision. (E) When available, a thumbnail of the structural prediction rendering is displayed in the header area. (F) Two drop-
down menus provide easy access to the top ten most recently visited and updated articles. (G) Vital information on the TF, such as its
classification, homologs, genomic links, and synonyms, occupy the top right corner of each page. (H) An article completion score bar provides
immediate feedback to the author on the progress of their articles. (I) Articles in TFe are organized into ten tabs. Immediately underneath, the
tabs are links to data downloads in PDF and Excel file formats. A ‘view content, comments’ toggle allows the user to view comments that have
been attached to the article. By default, comments are hidden from sight. (J) Most tabbed sections start with an author-contributed ‘summary’
paragraph that ranges in length from 150 to 500 words.
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information to a team of curators who review the infor-
mation for errors and, if appropriate, deposit the annota-
tion into the PAZAR database. Because PAZAR and TFe
are programmatically linked, the annotation deposited in
PAZAR will also appear in TFe.
Targets tab
Related to the ‘TFBS’ tab, the ‘Targets’ tab presents
users with an introductory text followed by a list of
genes directly regulated by the subject TF sourced from
the PAZAR database. At a minimum, the ‘Targets’ list
recapitulates the information in the ‘TFBS’ tab, but
oftentimes, expert authors provide additional genes
known to be regulated by the TF but for which the spe-
cific DNA target sequence is unknown. Authors can add
additional targets by using a specialized editing interface
that is accessible upon sign in.
Protein tab
The ‘Protein’ tab presents information about the func-
tional consequences of protein modifications or distinc-
tions between protein isoforms. Authors summarize
Figure 6 Content available in TFe. This diagram demonstrates the diverse range of TF-related content available in TFe. Articles in TFe are
organized into ten tabs. In this diagram, the ten tabs are represented by the ten horizontal columns labeled ‘Summary’, ‘Structure’, ‘TFBS’, and so
forth. Under each tab in the article, there exist one or more relevant subheadings. In this diagram, these subheadings are represented by beige
or grey boxes, which contain partial screenshots of the actual content - whether they are text, figures, or tables. Beige boxes represent content
that has been composed by TFe authors, while grey boxes represent content that has been largely automatically populated. Below each
screenshot box is the name of the subheading and a brief description of the subheading. Below the description are a series of blue, red, green,
and yellow icons labeled ‘WEB’, ‘PDF’, ‘XLS’, and ‘API’. As the names suggest, these icons indicate whether the content of that particular
subheading is available in various formats. All subheadings are available in web format - on the TFe website. Thus, we consider the TFe website
format as the most comprehensive format available. Select content is available in redacted form in the PDF format. Content that is in the form
of ‘data’ can be downloaded as an Excel spreadsheet (’XLS’) or retrieved using the TFe web API (’API’) from the TFe website.
Yusuf et al. Genome Biology 2012, 13:R24
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such information in free text entries. As a late addition
to the system identified as a need during the beta-test-
ing process, the section has yet to be populated for
many entries.
Interactions tab
Interactions between TFs and ligands or proteins are
reported in this tab. While automated content from the
BioGRID database is included, authors may also provide
information about additional interactions not reported
in the external system through a specialized submission
interface. Authors have a limited set of interaction types
(Table 2) from which to pick labels. If the gene encod-
ing the TF is subject to transcriptional regulation in a
selective manner, the regulating TFs are reported in this
section.
Genetics tab
TFs perform powerful genetic roles in the development
and physiology of organisms. Therefore, the genetic
properties of TFs can have powerful consequences upon
the phenotype of an organism. The ‘Genetics’ tab pre-
sents two sets of data linking TFs to phenotype, in addi-
tion to the prerequisite expert-written summary. The
first is a ‘cloud’ of TF-to-disease associations composed
with MeSH terms. The second set of data linking TFs to
phenotype is a list of Mouse Genome Database mamma-
lian phenotype terms associated with the mouse homo-
log of the TF protein.
Expression tab
The ‘Expression’ tab reports expression data from the
GNF Expression Atlas, sourced from the UCSC Genome
Browser, and observed regional expression in the brain
according to the Allen Brain Atlas. Authors are encour-
aged to provide a text description of known expression
properties of the TF gene.
Ontologies tab
Annotated characteristics of the TF are reported in the
‘Ontologies’ tab. Gene Ontology terms linked to the
gene are extracted from Entrez Gene for display. The
Table 1 Sources of automatically populated content
Tab Section Sources Use of sources
Structure Structures RSCB PDB, Pfam Structural predictions are made with the help of experimentally verified protein
structures downloaded from the RSCB PDB. In the process of creating the
structural predictions, we use the HMM database from Protein Families (Pfam) to
help us identify domains found in protein sequences in the RSCB PDB database
(which we use as templates) as well as the protein sequences of putative
structures we want to predict
TFBS TFBS logos PAZAR The logo in this section is generated with the Perl module MEME and its
dependencies, using binding site data from PAZAR
Binding site profiles PAZAR The logo and position frequency matrix in this section are generated with the
Perl module MEME and its dependencies, using binding site data from PAZAR
Targets Targets (author curated) Gene Ontology (NCBI) While the author provides the gene ID, TF complex, effect, and reference,
biological process GO terms associated with each target gene in this section are
imported from gene-to-GO annotations from NCBI
Targets (automatically
populated)
PAZAR, Gene
Ontology (NCBI)
Target gene, TF complex, and reference data are imported from PAZAR. The
author supplies effect data. Biological process GO terms associated with each
target gene in this section are imported from GO annotations provided by NCBI
Interactions Ligands (author curated) PubChem (NCBI) While ligand IDs, experiment types, natures of interaction and references are
supplied by the author, the ligand common name and image are provided from
PubChem
Interactions (automatically
populated)
BioGRID Interactor names, experiment types, and references are imported from BioGRID.
Natures of interaction are provided by the author
Transcriptional regulators
(automatically populated)
PAZAR, Gene
Ontology (NCBI)
Regulating TF complex, regulating TF, genomic links, and reference information
are provided by PAZAR. Biological process GO terms associated with each target
regulator in this section are imported from GO annotations provided by NCBI
Genetics MeSH cloud (automatically
populated)
MeSH (NCBI), Entrez
Gene, GeneRIF
MeSH term associations and Fisher’s exact P-values are generated using data
from NCBI MeSH, Entrez Gene, and GeneRIF
Expression Expression (automatically
populated)
UCSC Genome
Browser, Allen Brain
Atlas
Expression data in this section are imported from the UCSC Genome Browser
database, GNF Expression Atlas 2 dataset, and the Allen Brain Atlas
Ontologies Gene Ontology
(automatically populated)
Gene Ontology (NCBI) GO terms associated with the transcription factor in this section are imported
from GO annotations provided by NCBI
MeSH cloud (automatically
populated)
MeSH (NCBI), Entrez
Gene, GeneRIF
MeSH term associations and Fisher’s exact P-values are generated using data
from NCBI MeSH, Entrez Gene, and GeneRIF
Papers Papers PubMed Detailed information on relevant papers such as authors, titles, journals, and
publication dates are imported from NCBI PubMed.
Eight out of ten tabs in TFe articles contain one or more subheadings of automatically populated content. This table lists the direct sources of automatically
populated content by tab and subheading (’section’). GO, Gene Ontology; RSCB, Research Collaboratory for Structural Bioinformatics.
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automatically populated TF-to-MeSH associations for all
MeSH terms outside of diseases are reported, following
the same procedure as introduced in MeSHOP.
Papers tab
The ‘Papers’ tab provides a set of recommended articles
pertinent to the TF. Authors indicate the most useful
introductory readings and other key papers with a two
circle rating system. Two full circles indicate an excel-
lent paper in the author’s opinion, while no circles still
indicate a very good and noteworthy paper.
System features
In this section of the paper, we discuss the important fea-
tures of our platform. These features include: (1) our sys-
tem of classifying TFs; (2) our concept of ‘content
inheritance’, or how articles of very closely related TFs
may derive content from each other when biologically
appropriate; (3) our structural prediction system; (4) our
data on TF binding sites; (5) our TF-to-disease association
predictions; (6) our PDF rendering system; (7) TFe’s data
export capabilities; and (8) the article completion score.
Classification of transcription factors
The classification of TFs into ‘groups’, ‘families’ and ‘sub-
families’ is a very important feature of TFe. Over the past
few years, there have been efforts to identify and classify
all TFs within the human and mouse genomes [4,5].
While there are potentially several different strategies for
classifying TFs, one promising approach is to group them
based on DNA binding domain structures. Building upon
the work of Fulton et al. in the Transcription Factor Cat-
alog (TFCat) project [4], we have organized all TFs in
TFe into various groups, families and subfamilies as pre-
viously mentioned (Additional file 3).
Content inheritance
When comparing orthologous TFs, or recently evolved
paralogs within a species, it is commonly observed that
homologous TFs are well conserved structurally and
functionally [29]. Indeed, some homologous TFs are so
well conserved that there is often no information that
distinguishes the homologs. However, in TFe we have
opted to create separate articles for all TFs, including
homologous TFs. For instance, we have several articles
for the TF NFE2L2 - one each for human, mouse, and
rat. In doing so, we aim to provide maximum flexibility
to our authors who may wish to discuss key subtle dif-
ferences between closely related proteins.
The drawback to this approach is that, in some cases,
we end up with multiple articles for what could be con-
sidered as functionally synonymous TFs. These TFs, due
to their extreme likeness, would inevitably share com-
mon attributes such as binding site profiles, interactors,
and target genes. In this situation, it becomes important
to keep all shared attributes current and synchronized
across the different articles. To assist with this informa-
tion management process, we implemented a content
inheritance system that enables authors to define small
clusters of homologous TFs for which certain data may
be automatically shared. Under this system, the article
that is more annotated - the ‘parent article’ - donates
text, figures, and data as appropriate to the article that
is less annotated, the ‘child article’. However, authors
and editors are able to override the automatic sharing of
data when it is not reflective of the underlying biology.
Structural predictions
We have developed a custom computational pipeline for
predicting the three-dimensional protein structures of
the DNA binding domains of TFs. The final output of
our pipeline is a PDB formatted file of the predicted
structure, alongside a short segment of double-stranded
Table 2 List of predefined interaction types
Interaction type Gene Ligand
Acts on upstream signaling pathway •
Competitive inhibition • •
Genetic • •
Indirect • •
Multimerization • •
Not specified • •
Physical: deacetylation • •
Physical: dephosphorylation • •
Physical: desumoylation • •
Physical: deubiqiutination • •
Physical: enzyme modification: acetylation • •
Physical: enzyme modification: methylation • •
Physical: enzyme modification: phosphorylation • •
Physical: enzyme modification: protein cleavage • •
Physical: enzyme modification: sumoylation • •
Physical: indirect altering posttranslational modifications • •
Physical: sequestering • •
Physical: translocation • •
Physical: ubiquitination • •
Physical: undefined direct interaction • •
Physical: with another TF •
Physical: with another TF: complex binds DNA •
Physical: with co-activator affecting recruitment • •
Physical: with co-repressor affecting recruitment • •
Regulatory: decreases expression of this TF • •
Regulatory: increases expression of this TF • •
Unknown • •
When a protein-to-protein or protein-to-ligand is added to a TFe article either
by the author or automatically from BioGRID, the author of that article has the
option to define the interaction type if this information is known. To promote
a standardized vocabulary for describing interaction types, a list of possible
interaction types between proteins and ligands is provided to the author. This
list continues to be adjusted and expanded based on need and author
feedback.
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DNA for positional reference. The DNA molecules are
stylistic and do not represent particular sequences such
as the consensus sequence for the TF. We have gener-
ated standardized PNG image renderings of these PDB
files for web and print purposes. Figure 7 contains a
representative sample of the structural predictions, one
from each family of TFs featured in our first release. To
date, 212 structural predictions have been generated,
with the emphasis of effort focused on TFs with articles
that are nearing completion. All structural predictions
are available for download in PDB format under the
‘Structure’ section in the articles of their respective TFs.
A brief summary of the materials and methods used in
our protocol can be found in the Materials and methods
section below.
Transcription factor binding site data
One of the goals of TFe is to encourage experts to
assist in the curation of TFBS sequences and
generation of binding profiles. Working in partnership
with PAZAR [25], an open source and open access TF
and regulatory sequence annotation database, our con-
sortium gains access to a powerful curation platform
with which it can store, annotate, and manage data, as
well as retrieve additional data from other projects in
PAZAR. Our initial collection of 100 reviews collec-
tively contain 3,083 unique binding site sequences
from the PAZAR database, of which a total of 452
sequences have been donated to PAZAR by the con-
sortium. From this set of binding site sequences, we
have generated 221 binding models and extracted
1,436 genomic targets for 199 different TFs. In addi-
tion, 898 genomic targets have been entered manually
by our authors to supplement this genomic target
dataset. See Additional file 2 to see the binding data
of released articles and Additional file 5 for key bind-
ing profiles that have been generated in the TFe
project.
Figure 7 Structural predictions of TF DNA binding domains. To date, we have created 212 structural predictions of the active sites of select
TFs in TFe. We focused on TFs for which a structural prediction is most feasible and whose articles are nearing completion. These predictions
were generated with an in-house, custom-made pipeline that finds the most similar, experimentally determined protein structure for each
unsolved TF, and uses that experimentally determined ‘template’ to guide the prediction of the unknown structure.
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Disease associations
Many TFs are implicated in disease. Out of a growing
list of 1,321 human TFs we compiled from the work of
Vaquerizas et al. [5] and Fulton et al. [4], 197 are cur-
rently linked to one or more diseases in the OMIM
Morbid Map [30]. In light of the strong connection
between TFs and disease, we have predicted 42,500 TF-
to-disease associations. This was done by using the
‘Entrez Gene to PubMed’ (’gene2pubmed’) and MeSH
datasets that are available at the National Center for
Biotechnology Information (NCBI). With mainly these
two datasets, with additional datasets such as OMIM
and GeneRIF to further strengthen our predictions, we
developed a protocol that makes the connection
between TF-encoding genes, papers that discuss these
genes, and the MeSH terms that are tagged to the
papers. By indirectly mapping disease-oriented MeSH
terms to TF-encoding gene identifiers, we are able gen-
erate a list of MeSH terms that are associated with each
TF. Statistical analysis is applied to the raw connections
to determine their strength - mainly by reflecting the
frequency of TF-term co-occurrence in light of the
number of papers that refer to either the TF or the
term. This information can be viewed as a table or as a
‘cloud’ under the ‘Genetics’ tab.
PDF rendering
We have built a PDF rendering engine in TFe that
transforms articles into condensed, four-page PDF ‘mini
summaries’ available for printing (Figure 8). These sum-
maries can be downloaded by clicking on the ‘Download
article (PDF)’ link that is prominently displayed on all
article pages on the TFe website. We have included a
sample in Additional file 1.
While the articles as they appear on the TFe website
permit great flexibility in terms of length and variety of
content, the PDF format is more structured and com-
pact. Thus, the PDF version of the articles can be
described as the ‘abridged’ form of the article. When
necessary, we are keen to remind users that there is
additional content on the TFe website that cannot be
incorporated into the abbreviated PDF article.
In our effort to encourage authors to write more
balanced articles that fulfill the prescribed style, we
ration the available space for each section. For instance,
one third of the last page is strictly allocated to the
Genetics and Expressions paragraphs. If an author
chooses not to comment on those sections, that space
will remain blank - to motivate authors to do something
about it. Conversely, if the author provides more text
than allowed, the surplus text will simply be trimmed to
the nearest sentence.
The PDF feature was created to produce an article
format that more closely resembles a ‘journal paper’,
with pleasant typesetting and pagination. Indeed, many
open source journals that publish exclusively online still
invest significant resources to generate definitive PDF
copies for all of their articles, even when HTML ver-
sions are adequate for practical purposes. We envision
that for some users, once a TF has significantly piqued
their interest for further perusal, they would be inclined
to review the web version to access the most complete
and up-to-date information.
Behind the scenes, our PDF rendering engine is based
on in-house code and the dompdf 0.5.1 open source
module. It uses fuzzy logic to handle the modifications
necessary to determine the best solution of text, images,
captions, and data tables to make the page layouts as
aesthetically pleasing as ‘machinely’ possible. These
modifications include changing the sizes of the figures,
truncating excess text, reformatting the references, and
calculating trade-offs between having larger figures and
more data in data tables at the expense of less text, or
keeping more text at the expense of having fewer figures
and sparser data tables.
Data export
One of the goals of TFe is to make TF data easily acces-
sible to all. To support this goal, we built a web-based
application programming interface (API) to facilitate a
straightforward approach for extracting data from the
TFe website. In addition to the TFe API, we have built a
spreadsheet generator that allows visitors to download
Excel (.xls) formatted files containing all of the informa-
tion that is available through the web API, as a service
for users who are not inclined to use the programmer-
oriented web API. In short, virtually all forms of data
available in TFe, including binding sequences, genomic
targets, interactors, key papers, and even ontology
terms, can be downloaded through the API, the spread-
sheet generator, or PDF renderer. The TFe web-based
API and its accompanying documentation can be found
on the TFe website.
The presence of a machine-friendly API is what sets
TFe apart from most other biomedical wikis. For easy
parsing, the API sends data in tab-delimited plain text
format. Since the API is web-based and communicates
through the ubiquitous HTTP protocol, it is compatible
with all common scripting and programming languages,
including PHP Hypertext Preprocessor (PHP), Perl, and
Python. See Figure 9 for an illustration of how the data
retrieval process works when using the TFe web API.
Article completion score
An article completion score (ACS) is automatically com-
puted for every article in TFe. The ACS can range from
0% to 100%. Its purpose is to reflect the depth of anno-
tation present in the article - the article’s level of
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completeness. To illustrate, nearly complete articles
typically have an ACS of 90% or more. The ACS is pro-
minently displayed in the header of all articles on the
TFe website in the form of a ‘progress bar’ that changes
from orange to green as the score approaches 100%
(Figure 5). The ACS system is designed to help authors
determine whether their articles are sufficiently com-
plete, and more importantly, identify article sections
that are in need of more attention. By clicking on the
‘see what’s missing’ link to the right of the progress bar,
authors can view a list of suggestions that they can
undertake to increase the score of their article, such as
‘please provide more information in the Overview sec-
tion of the Summary tab.’
The ACS evaluates the completeness of TFe articles
based on several factors, which include, among others, the
amount of text, figures, references, and data contributed
for each article. Overall, 19 attributes (Table 3) are taken
into account in the computation of the ACS.
The ACS was implemented during TFe’s beta testing
period, when we observed that authors need guidance as
to the expected level of article content. Prior to the
implementation of the ACS, a large majority of ‘com-
pleted articles’ were deemed substantially incomplete.
The ACS metric has established a standard for author
contribution and helps authors attain this standard by
highlighting sections of deficient articles that require
further attention, and notifies authors how the deficiency
can be remedied. While developed de novo, subsequent
feedback indicates that the progress tracking scores are
reminiscent of content tracking scores utilized in the Lin-
kedIn social networking system. The response to the ACS
has been positive. Within six months of implementation,
the completion scores of all articles increased from 40.6%
to 60.2% (Figure 10). The scoring metrics for computing
the ACS are presented in Table 3.
User authentication
The user authentication system of TFe, which handles
the ‘sign in’ and ‘sign out’ functions, is built upon the
Perl CGI::Session module. All account passwords stored
in the TFe database are encrypted to safeguard the priv-
acy and security of TFe users.
Software
In this section, we discuss in technical detail the soft-
ware that runs the TFe website, mainly its user interface
and system architecture.
Figure 8 Format of the PDF article. The PDF mini summaries are composed of four pages. The first page features basic information such as
the TF name, gene identifiers and classification, as well as author information. Also on the first page are the names and affiliations of the
authors, an overview of the TF, an image of its active site protein structure accompanied by a brief commentary, and a featured TF binding
profile selected by the author. The second and third pages contain a mixture of figures, paragraph text, and tables of genomic targets and
protein as well as ligand interactors. The last page contains two brief paragraphs, a MeSH cloud, and selected references. These are the first two
pages of a four-page PDF mini summary generated by the TFe system software. Our PDF creation tool, based on in-house code and the
dompdf 0.5.1 open source module, is able to format a TFe article of any length and annotation depth as a standardized four-page PDF article. A
fuzzy logic algorithm does all of the modifications necessary to make the conversion. These modifications may include changing the sizes of the
figures, truncating excess text, reformatting the references, and calculating trade-offs between having larger figures and data tables at the
expense of less text, or keeping more text at the expense of having fewer figures and smaller data tables.
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Figure 9 Using the TFe web API. Adventures in bioinformatics often involve large amounts of data retrieval and computation not amenable to
manual labor. Thus, in place of humans, software is written to automate the grunt work, which may include computing vast quantities of data
or obtaining large amounts of information from resources in the cloud, such as NCBI. To give researchers the option to retrieve data from TFe in
an automated fashion, we have implemented a simple yet powerful web API. This figure provides a summary of what a data transaction may
look like when using the TFe web API. In this case, the goal of the data retrieval exercise is to obtain all MeSH disease terms associated with the
transcription factor ‘ATF3’.
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Overview
The TFe software is a database-driven website applica-
tion that runs the TFe website. For end users, the TFe
website is an information resource where researchers
can read peer-reviewed, expert-written summaries on
pertinent TFs as well as obtain a wide variety of TF-
related data, including binding sequences, genomic tar-
gets, and TF-to-disease associations. See Figure 6 for a
complete list of all types of information available on
TFe.
As previously discussed, the TFe website also features
a password-protected user interface that allows expert
authors to create and edit TF articles, upload data,
report technical problems (that is, bugs), and submit
anonymous peer reviews of other articles. It also fea-
tures a built-in Customer Relationship Management
(CRM)-like tool to help the administrators recruit new
authors, as well as manage and communicate with the
rest of the consortium. In short, the TFe website is a
specialized and integrated software platform that has
Table 3 Computing the TFe Article Completion Score
Tab Scoring element Target Points Weight
Summary Overview text 500 words 10 points 8.333%
Summary References in overview text 3 references 5 points 4.167%
Summary Figures 1 figure 10 points 8.333%
Structure Overview text 200 words 5 points 4.167%
TFBS Overview text 150 words 5 points 4.167%
TFBS Binding site profiles 1 binding site profile 10 points 8.333%
Targets Overview text 200 words 5 points 4.167%
Targets Targets 10 targets in total (both author and auto) 10 points 8.333%
Protein Isoforms text 200 words 5 points 4.167%
Protein Covalent modifications text 200 words 5 points 4.167%
Interactions Overview text 200 words 5 points 4.167%
Interactions Ligands 1 ligand 1 point 0.833%
Interactions Interactions 10 interactors in total (both author and auto) 10 points 8.333%
Interactions Interactions All ‘nature of interaction’ fields annotated 10 points 8.333%
Genetics Overview text 250 words 5 points 4.167%
Expression Overview text 200 words 5 points 4.167%
Papers Papers 15 papers 10 points 8.333%
Papers Papers 3 papers marked as ‘recommended’ 3 points 2.500%
(all) Links 1 link 1 point 0.833%
120 points 100%
The TFe Article Completion Score (ACS) is based on the 19 components listed here. Authors earn points for completing each component, up to the prescribed
maximum for that component (’Maximum points’). So, for example, an author would be granted one point for adding one link, but no additional points would
be granted if the author adds a second or third link. This prevents the author from adding 24 links to boost their ACS score by 20%. A ‘fully complete’ article
would net 120 points, which gives a score of 100%.
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Figure 10 The completion scores of authored articles in TFe. The y-axis of this graph is the article completion score (ACS), while the bars on
the x-axis represent the 176 authored TF articles in TFe (some of which are still works-in-progress), ordered such that higher scoring articles are
positioned on the right (for clarity). In this graph, the completion scores of the 176 articles from three different periods - Q2 2009, Q4 2009, and
Q2 2010 - are superimposed to demonstrate that the scores have been increasing over time. Within six months of the implementation of the
ACS system in Q2 2009, the completion scores of authored TFe articles have increased from 40.6% to 60.2%, thus attesting to the effectiveness
of this feedback mechanism (see Q2 2009 versus Q4 2009).
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been custom-built to facilitate a community-curated TF
wiki project.
User interface
The TFe website, which can be accessed at [18], features
a familiar and streamlined graphical user interface that
is written in Extensible Hypertext Markup Language
(XHTML) 1.0 Transitional, Cascading Style Sheets
(CSS), and JavaScript.
On the homepage, a large ‘universal’ search box domi-
nates the center of the screen (Figure 4a). This search
box allows users to quickly access TFe’s built-in search
engine, which accepts 18 different types of queries,
including gene symbols, fragments of binding sequences,
and the names of researchers who are associated with
particular TFs through their publication records. Alter-
natively, visitors can click on the ‘go to a random article’
link to view a random article on the article page.
Displayed in Figure 4b and as previously discussed, the
article page is the centerpiece of the TFe-user interac-
tion as it is where the bulk of TFe content lies. It fea-
tures a compact yet informative and graphically rich
header with key pieces of information about the TF, fol-
lowed by the described ACS indicating the TF article’s
level of completeness or ‘depth’. Below the ACS, the
contents of the article are divided into ten tabs labeled
‘Summary’, ‘Structure’, ‘TFBS’, ‘Targets’, ‘Protein’, ‘Inter-
actions’, ‘Genetics’, ‘Expression’, ‘Ontologies’, and
‘Papers’. A row of navigation links is placed unobtru-
sively on the left side of the page. Other noteworthy
pages on the TFe website include the classification page
(Figure 4c) and the browse page. The classification page
presents an organized hierarchy of TFs based on the
TFCat [4] and the extended TF classification system of
Vaquerizas et al. [5]. The browse page allows users to
browse for TF articles based on various attributes such
as name, classification, and level of completeness.
System architecture
The TFe website software is written almost entirely in the
Perl programming language, using the ‘LAMP’ (Linux,
Apache, MySQL, Perl/PHP) paradigm for developing web-
based applications. The Perl programming language was
chosen for its robust text-manipulation capabilities and
widespread support within the bioinformatics research
community. In developing the website software, we have
incorporated Perl and PHP modules and software
packages to handle specialized tasks - such as reading the
database, generating PDF files, and resizing images. See
Table 4 for a list of Perl and PHP modules and software
packages incorporated into the TFe software.
The TFe website software is designed to run quickly
and efficiently, yet remain relatively simple for program-
mers and system administrators to maintain. One
challenge we had to overcome during the development
process was keeping the software fast and responsive
despite its size and complexity. One solution was to pur-
posefully fragment the TFe website software into over 40
independent components. Each component serves a sin-
gle unique purpose - for instance, to generate the home
page, or to search the database, or to display articles.
Each component can be summoned separately and with-
out disturbing the other components. This fragmentation
allows us to improve the speed and responsiveness of the
TFe website, as at any given time only a fraction of the
entire TFe software is being executed by the server.
To reduce code repetition, we placed shared functions
- such as those that generate the page header or naviga-
tion links - in a shared module that can be summoned
by any component as needed. We call this module the
‘TFe core module’ because it forms the nucleus of the
TFe website software. To further increase speed, we
divided this TFe core module into three separate com-
ponents: (1) a component that contains the vast majority
of shared functions called ‘tfe.pm’; (2) a component that
contains only those functions involved with database
reads and writes called ‘db.pm’; and (3) a component
that deals with maintenance and update functions called
‘update.pm’. See Figure 11 for a schematic representa-
tion of the TFe website software.
With regards to hardware architecture, the TFe web-
site software is currently implemented in Linux-based
(CentOS) environment using a dedicated virtual server.
The TFe software stores data in both the UNIX file sys-
tem (that is, for images and PDF files) and a MySQL
database, both of which are physically located in a
Table 4 Perl and PHP modules used in TFe
Language Module Purpose
Perl CGI Web browser interface
Perl CGI::Session User login
Perl Crypt::Blowfish Data encryption and random string
generation
Perl DBI MySQL database interface
Perl GD::Image Creation of TF binding site diagrams
Perl HTML::Detoxifier User input filtering
Perl Image::Resize Image resizing and formatting
Perl LWP::Simple Interface between TFe and web-based
APIs
Perl pazar Data retrieval from PAZAR
Perl pazar::gene Data retrieval from PAZAR
Perl pazar::reg_seq Data retrieval from PAZAR
Perl TFBS::PatternGen::
MEME
Creation of TF position weight
matrices
PHP dompdf 0.5.1 PDF generation
Listed on this table are the second and third party modules incorporated into
TFe, with their respective programming languages, usage in TFe, and current
web addresses at the time of publication.
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proximal storage area network. To share computational
load and optimize service responsiveness, a dedicated
database server executes all complex database queries.
This database server is connected to both the primary
TFe web server and storage area network via fiber optic.
Development process
The TFe system was developed over a period of three
years. Early prototypes in 2007 were subjected to
intense testing and continuous refinement by the pro-
gramming team during what we refer to as the ‘pre-
alpha stage’. In the 2008 ‘alpha stage’, external quality
control testing was initiated by inviting ten authors to
provide feedback on the software’s design, features, and
usability. By 2009, the software had evolved to a more
stable and mature form. At this ‘beta stage’, we invited
over 100 TF experts from around the world to contri-
bute articles.
Figure 11 Software architecture. This schematic demonstrates the conceptual structure of the TFe software. Written mainly in the Perl
programming language, the software is essentially a collection of Perl ‘scripts’ that runs on an Apache web server, in a UNIX-compatible
environment. The software relies on MySQL for data storage, and a number of third party modules. Over 40 ‘front line’ scripts (shown as the red
rectangle) generate individual pages such as the home page and article page. These front line scripts are backed by a cluster of three TFe Perl
modules (shown as the green circles): (1) the ‘database updater’, which is summoned pro re nata whenever the TFe database needs to be
maintained or updated with new content from external sources such as NCBI; (2) the ‘main module’, which contains shared subroutines such as
those that generate page headers; and (3) the ‘database handler’, which forms the gateway between all components of the TFe software and
the TFe database. The database (shown as the yellow cylinder) is stored on a separate database server and communicates with the rest of the
TFe software via fiber optic. It contains cached copies of third party resources so that the TFe software does not have to constantly retrieve data
from the ‘cloud’. This optimizes performance. The web API (shown as the purple rectangle) is directly connected to the ultra small and efficient
database handler module. In bypassing activation of the large main module and database updater, the web API is able to run faster than the
web-based interface. GO, Gene Ontology; MGI, Mouse Genome Informatics.
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Over the next six months, TF experts responded to
our invitations and began producing articles. To cope
with the influx of feedback, we implemented an online
feedback form. We upgraded our bug tracking process
by adopting MantisBT, a web-based system that is avail-
able at [31]. All feedback was reviewed and prioritized
for system modification if justified. Small changes were
addressed immediately.
A rigorous backup regimen occurs on a daily and
weekly basis to help us quickly and fully recover in the
event of catastrophic system failure.
Discussion
Three prominent systems have been introduced that rely
more heavily on the community-contributed content
wiki model. These are: (1) WikiProteins [32]; (2) Wiki-
Genes [13]; and (3) Gene Wiki [14]. WikiProteins uses
automated procedures to extract information from mul-
tiple resources, a text-based procedure to summarize
these data, and a wiki-based format to collect user-sup-
plied information. Similarly, WikiGenes uses a text-
based procedure based on the iHOP service to present
automated content organized under categorized subjects,
and users are encouraged to provide content and cor-
rections to the system, with their identities displayed to
acknowledge contributions. Gene Wiki, the product of
which resides within Wikipedia, automates the creation
and maintenance of ‘stub’ articles on genes, thus creat-
ing a systematic framework for gene content. Despite
the quality of these systems, examples of deep commu-
nity commitment to contribute content are rare. By
visual inspection, most entries in these systems still con-
tain mostly automated content.
A striking divergence from the classic model is Gen-
eTests [33], in which expert authors are recruited for
each subject gene, taking intellectual ownership of an
article of substantial importance to the clinical genetics
community. When contrasting GeneTests to the afore-
mentioned wiki-based systems, two qualities contribute
prominently to the success of the former. First, GeneT-
ests addresses a niche, allowing content to be tailored to
the needs of a target audience. Second, the scientists
who write articles on GeneTests are strongly acknowl-
edged, allowing them to receive recognition for their
intellectual contributions. While lasting participation in
- and the continuing evolution of - GeneTests may ulti-
mately derive from the intense commitment of the pro-
ject’s directors, it stands out as one of the rare cases in
which prominent genetics researchers contribute origi-
nal content to a community resource.
TFe represents a new direction in scientific communi-
cation of gene-specific information. Combining auto-
mated data presentation with expert-user reviews, the
wiki-based system provides succinct reports about TFs,
one of the most highly studied classes of proteins. The
highly engaged efforts by researchers worldwide demon-
strate that a wiki-based system can attract active partici-
pation and meet high quality standards of scholarly
content. With over 100 mini reviews presented in the
initial release, TFe represents one of the largest commu-
nity participations in a gene-focused wiki project.
While the term wiki has become loosely applied over
the years, in reality the term refers to a specific class of
software that allows shared development of a document.
However, in its most basic sense the term is commonly
used to reflect the philosophy that information is best
made accessible and editable by anyone pro bono. The
wiki model has caught the attention of some scientists,
who see it as a powerful tool that can hasten the pace
of scientific communication. In the wake of Wikipedia’s
success, there emerged a high profile rallying call to cre-
ate a gene-function wiki for scientists [34], and several
groups have heeded this call by creating various scienti-
fic wikis, some built from the ground up [13] and some
derived from existing general purpose wiki engines
[32,35].
Unfortunately, as evidenced by WikiProteins [32],
WikiGenes [13], and to a lesser extent Gene Wiki [14],
scientific wikis have generally struggled to attract the
level of community involvement envisioned by their
founders. There are several contributing influences for
the observed low rate of participation. The success of
Wikipedia is in part attributable to the enthusiasm of a
tiny fraction of the large global community of Internet
users who are willing to contribute content. The scienti-
fic community with expertise on a specific topic, on the
other hand, is small. Thus, even if the participation rate
among these scientists remains comparable to the parti-
cipation rate of the global community of Internet users
who contribute content to Wikipedia, there would still
be far fewer scientists contributing. To make matters
worse for proponents of scientific wikis, scientists seem
generally less willing to participate in these sorts of
endeavors than the average user, reflecting perhaps the
enormous demands on their time or the relative age of
the experts. For many, their limited time is dedicated to
rewarding tasks, such as performing experiments and
reporting on the results in peer-reviewed journals. Earn-
ing new publications appears to be a strong motivator
for many scientists. Few are willing to spend the same
amount of time and effort to expand a wiki article that
resides in the public domain and from which they
would not receive any substantial credit.
Recognizing these constraints, a critical component of
the success of TFe is the provision for authorship credit.
Furthermore, we strive to actively identify and recruit
authors, as opposed to waiting for contributors to con-
tact us. Without addressing these two aspects, we doubt
Yusuf et al. Genome Biology 2012, 13:R24
http://genomebiology.com/2012/13/3/R24
Page 18 of 25
that we would be able to attain the same level of com-
munity involvement. Ultimately, the support of a journal
willing to publish the resulting mini reviews in the form
of this article (subject to passing a peer-review process)
was a key motivator for many authors to participate in
the project.
The retention of peer-review within the wiki-based
article development process is scientifically critical.
Readers of the system must hold high confidence in the
quality of the reports. To meet this standard, all partici-
pating authors were encouraged to provide anonymous
peer review reports for a set of articles. Approximately
40% of TFe authors participated in this voluntary peer
review program as peer reviewers of other TFe articles.
Author identification was a challenge. We initially
sought participation from existing collaborators and
subsequently from peer referrals. During this early part
of the project, we were able to recruit a core team of
about ten authors who also became our de facto ’alpha
testers’, thus allowing us to incorporate user feedback
during the application development process. These
authors - and eventually other authors as well - had sig-
nificant input into the TFe system throughout its
formation.
Given the large number of characterized TFs, we ulti-
mately needed a larger-scale approach. To this end, we
identified researchers who frequently appeared as the
senior author in publications that discuss a specific
human or mouse TF (using an automated analysis of
articles in PubMed). Overall, 251 authors were individu-
ally contacted via email. About 59% (149 authors)
agreed to participate, in addition to 10 authors who
were directly invited at the outset of the project, and 2
authors who expressed interest and joined without invi-
tation. About 65% of the participants developed articles
sufficiently for inclusion in this report.
Moving forward, TFe can be expanded, advancing the
effort to the ultimate goal of a high-quality article for
every human TF. For the future, we plan to adopt a
more targeted approach by working with communities
of authors who represent specific structural groups of
TFs (for example, nuclear receptors) or TFs that func-
tion within a specific biological context (for example,
diabetes). Such efforts can be partnered with sponsoring
journals that agree to reward the community efforts
with a citable publication.
Citing the resource
To cite TFe as a concept or software tool, cite this
paper. To cite specific mini review articles found on the
TFe website, please use the following format when
possible:
Author(s) last name followed by initials: < TF symbol
in bold and proper capitalization >. In Yusuf D et al.:
The Transcription Factor Encyclopedia. Genome Biol-
ogy 2012, 13:R24.
Example:
Bolotin E, Schnabl JM, Sladek FM: HNF4a. In Yusuf
D et al.: The Transcription Factor Encyclopedia. Gen-
ome Biology 2012, 13:R24.
Conclusions
TFe is a new web-based platform for facilitating the col-
lection, evaluation, and dissemination of TF data. It is
organized and curated by a consortium of TF experts
from around the world whose goal is to develop concise
mini review articles on pertinent human and mouse
TFs. TFe contains a wealth of TF information consisting
of both automatically populated and manually curated
content. Over 100 released articles are currently avail-
able, with more to come. By offering multiple data
export options that include the web API, the PDF gen-
erator, and spreadsheet generator, TFe strives to be a
convenient and accessible resource. The TFe is available
at http://www.cisreg.ca/tfe.
Materials and methods
TFe is an amalgamation of several different and highly
involved projects. For the sake of brevity, here we pre-
sent only the most important key points regarding the
materials and methods we employed in creating TFe.
Thus, we selectively describe the materials and methods
used in creating: (1) our TF classification system; (2)
our TF binding profiles; (3) our TF protein structure
predictions; and (4) our TF-to-disease associations. We
describe the latter two in greater detail.
Transcription factor classification system
With few exceptions, all TF genes and classification
information in TFe were sourced from TFCat, a large
collection of predicted and confirmed mouse TF genes
[4]. This collection is based on Entrez Gene identifiers.
However, not all TF genes described in TFCat were
added to TFe, as TFe is focused on those TFs that bind
directly to DNA in a sequence-specific fashion. Thus,
with few exceptions, only TFs tagged with the function-
based taxonomy of ‘DNA-Binding: sequence specific’ in
TFCat were added. Ultimately, out of about 1,764
mouse TF genes catalogued in TFCat, 585 were suitable
enough to be imported from TFCat to TFe.
TFs in TFe are organized into ‘groups’ and ‘families’
based on their DNA binding evidence and transcrip-
tional activation functions. This method of TF classifica-
tion is inherited from TFCat. ‘Groups’ of TFs represent
the highest level of organization in this classification sys-
tem. Within each group exist different ‘families’ of TFs.
For nuclear receptors, this classification system is
further extended with a ‘subfamily’ category. Placement
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of nuclear receptors within the subfamily category is
guided by recommendations from the Nuclear Receptors
Nomenclature Committee [36]. For a comprehensive list
of the groups, families, and subfamilies that are repre-
sented in TFe, refer to Additional file 3.
Transcription factor binding profiles
Most of the profiles in TFe are generated through man-
ual curation. Binding site data from our authors are sub-
mitted via a web-based form. Submissions were
processed by the curatorial staff of the PAZAR database
who confirm the quality of the submitted information
and enter the data into the TFe division of the PAZAR
database. Authors may submit either genomic coordi-
nates or TF binding motifs, such as those generated in
selection and amplification experiments.
Protein structure predictions
In summary, DNA binding transcription factors have
been extensively studied and can be grouped according
to a structural classification system [4]. For each of the
small set of structural domains known to facilitate
sequence-specific protein-DNA interactions, solved pro-
tein structures have been reported. Thus, it is feasible to
produce homology-based models for many DNA-bind-
ing domains of proteins represented in TFe by using
these solved protein structures as templates.
We generated a set of 202 predicted protein struc-
tures–homology-based predictions of the DNA binding
domains of TFs. To do this, we developed a custom
pipeline, written in Python, that incorporates two tools
well-known in the realm of protein studies: HMMER
[37] and Modeller [38]. Our protocol is based on the
work of Morozov and Siggia [39], in which templates
are selected to optimize similarity of DNA-binding resi-
dues. This method has been shown to increase modeling
accuracy at the DNA-binding interface.
There are three main steps in generating the struc-
tural predictions: (1) building the template library; (2)
finding a suitable template for each unsolved structure
we would like to model; and (3) creating the structural
prediction using the template as a guide.
Building the template library
We downloaded the entire RCSB PDB database [40] and
the Protein Families (Pfam) Pfam-A HMMs database
[41]. Using a custom Python script, we identified and
extracted records from the PDB database that appear to
contain a DNA binding domain and depict a protein-
DNA binding interface (see Additional file 6 for a list of
PDB records extracted). Each record is fragmented into
one or more files, such that each file contains only one
chain and the DNA residue. Using HMMER and the
Pfam-A HMMs database, we analyzed each fragmented
PDB record to catalogue all Pfam domains contained in
the protein sequence. The result of this exercise is a list
of relationships between Pfam domains and PDB
records (Additional file 7). This constitutes our template
library.
Finding a suitable template for each unsolved structure
For each unsolved TF protein structure, we looked for
Pfam domains in the protein sequence by reviewing pro-
tein domain annotations provided by Entrez Gene. Since
we are focused on modeling just the DNA binding
domain of the TF protein, we removed the rest of the
protein sequence. We then looked for templates in our
PDB set that contain the same Pfam binding domains.
We take these matching templates and compare each
individually with our unsolved protein structure until
the most suitable template is found. Our comparisons,
which are done by an alignment tool, are scored based
on similarity of the DNA-binding domain residues. For
TFs known to form homodimers, a homodimeric tem-
plate is selected.
Creating the structural prediction
After the most appropriate template is found, we input
the unsolved protein sequence and the chosen template
to Modeller 9v2, which constructs the predicted struc-
ture. After the structure is complete, we transfer the
DNA residue from the template to the model by super-
imposing the two protein structures in three-dimen-
sional space to find the most optimal superimposition,
copying the DNA residue from the template to the
model, and transposing the DNA residue per the super-
imposition coordinates. As mentioned earlier, the DNA
molecules are stylistic and do not represent particular
sequences - for example, the consensus sequence for the
TF. The final predicted structure is rendered using iMol
for presentation on the website.
Transcription factor to disease associations
TFs are a class of proteins that are highly implicated in
disease. Thus, we have made disease annotations an
important component of TFe. Under the ‘Genetics’ sec-
tion of all TFe articles, we have implemented a ‘cloud’
report of associated MeSH disease terms, along with
their respective P-values. These annotations were gener-
ated in-house using a novel pipeline. Conceptually, the
pipeline works as follows.
In PubMed, most - if not all - articles are tagged with
a list of MeSH terms by NCBI curators. Some of these
terms refer to diseases such as ‘Diabetes Mellitus, Type
2’ or ‘Aniridia’. In addition, articles are often tagged
with the identifiers of genes that are featured promi-
nently in the report. Ultimately, an article is tagged with
a list of MeSH terms, and also a list of genes. In TFe,
we have leveraged these annotations to infer associations
between TFs and certain diseases. For instance, muta-
tions in the TF PAX6 are causal for the genetic disorder
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aniridia [42]. An automated analysis of all PAX6-refer-
ring articles identifies the term ‘Aniridia’ as appearing
far more often than expected by chance (Fisher’s exact
P-value 3.2 × 10-184).
In the end, we generated 58,807 predicted TF-to-dis-
ease associations for the TFs in TFe (mean of 74.2 asso-
ciations per TF) with a scoring threshold of 0.05. These
associations can be viewed under the ‘Genetics’ tab on
the TFe website. An overview of our approach is as
follows.
Creating the associations
We derived these associations utilizing data from
PubMed and Entrez Gene. In the PubMed database, the
publications indexed in PubMed are associated with
MeSH terms. For instance, in PubMed, a publication
about the well-characterized gene TP53 may be asso-
ciated with the MeSH terms ‘Cell Line, Tumor’, ‘Onco-
gene Proteins, Fusion’, ‘Tumor Suppressor Protein p53’,
and the like. We refer to this set of data as ‘mesh2-
pubmed’ as it links MeSH terms to PubMed references.
In the Entrez Gene database, there similarly exists the
‘gene2pubmed’ dataset that associates PubMed refer-
ences with genes. Given these resources, it is possible to
create a link between genes and MeSH terms through
PubMed references. The end result is a set of ‘many-to-
many’ associations between MeSH terms and genes,
such that each MeSH term is associated with numerous
genes, and vice versa. As MeSH is a hierarchical con-
trolled vocabulary maintained by curators and only the
most specific relevant terms are ultimately associated
with each PubMed article, each MeSH term is expanded
to include all of its more generic parent terms. For
instance, the MeSH term ‘Diabetes Mellitus, Type 2’
would be expanded to include ‘Diabetes Mellitus’, ‘Glu-
cose Metabolism Disorders’, ‘Metabolic Diseases’, and
‘Nutritional and Metabolic Diseases’ (the latter being the
broadest and most generic term).
Following this exercise we are left with millions of
gene to MeSH associations, and - in particular - 662,163
associations between TF-encoding genes and MeSH
terms. Yet, not all associations are informative. For
instance, the MeSH term ‘Humans’ is associated with
many genes and - in practice - offers little annotation
value. On the other hand, the association - or multiple
associations - of a relatively rare term such as ‘Leuke-
mia, Erythroblastic, Acute’ with a TF-encoding gene
may offer greater insight into the function of that gene.
To evaluate the quality of these associations, we com-
puted Fisher’s exact test P-value scores (Equation 1) for
each TF to MeSH term association. In this equation, n
is the number of articles associated with the gene via
‘gene2pubmed’; k is the number of n articles associated
with the gene annotated with the MeSH term; N is the
number of articles in PubMed; and m is the number of
articles in PubMed annotated with the MeSH term. For
the background set, we compute the average rate of
occurrence for all possible gene-to-MeSH term associa-
tions, taking into account not only whether an associa-
tion exists, but also how often the same association
occurs in each gene. In short, relatively rare MeSH
terms that are associated multiple times with the same
gene will yield a low (significant) P-value, while rela-
tively common MeSH terms that are associated a few
times with the same gene will yield a high (insignificant)
P-value. We have not applied corrections for multiple
hypothesis testing in our P-values, although we plan to
implement this option in the future.
Pr(K ≤ k) =
k∑
i=0
(m
i
)(N −m
n− i
)
(
N
n
) (1)
On the TFe website, these data are displayed to the
user through the use of MeSH term clouds, where click-
ing on a term in the cloud launches a PubMed search
displaying the relevant articles.
This procedure resulted in 662,163 TF to MeSH term
associations, 333,909 of which return a P-value of ≤
0.05. About 58,807 of these associations are of TFs in
the TFe database. Overall, TFs are significantly linked to
2,121 out of over 4,400 disease terms described in the
MeSH vocabulary.
Additional material
Additional file 1: PDF of released article. The PDF version of the
human FOXL2 article. Other PDF versions of released TFe articles can be
accessed on the TFe website.
Additional file 2: Data of released articles. Additional data related to
the released mini review articles to supplement the four-page PDF
versions, arranged in alphabetical order by TF name.
Additional file 3: Classification of transcription factors in TFe. There
are 803 human, mouse, and rat articles in TFe, most of which are
organized into groups, families and subfamilies of TFs. The classification
scheme utilized in TFe is derived from the work of Fulton et al. [5] in
TFCat. There are 8 large groups, which are further subclassified into 34
families. Several TFs, namely nuclear receptors, are even further
subclassified into subfamilies.
Additional file 4: The TFe article structure. Articles in TFe are
organized into ten tabs labeled ‘Summary’, ‘Structure’, ‘TFBS’, ‘Targets’,
‘Protein’, ‘Interactions’, ‘Genetics’, ‘Expression’, ‘Ontologies’, and ‘Papers’.
Each tab, with the exception of the Ontologies and Papers tabs, typically
begins with a brief overview written by the authors, followed by a
mixture of tables and figures that features data from both the authors
and second (that is, PAZAR) or third party (that is, BioGRID) sources.
Additional file 5: Binding models produced in the TFe project.
Images of the binding models produced in TFe that are sufficiently
characterized to be used in a study.
Additional file 6: PDB records depicting protein-DNA binding
interface. A list of PDB records that depict a protein-DNA binding
interface.
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Additional file 7: Relationship Between Pfam domains and PDB
records. A list of Pfam binding domains followed by PDB records in
which the domains can be found.
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